Daniel M. Lipinski

1.2k total citations
38 papers, 916 citations indexed

About

Daniel M. Lipinski is a scholar working on Molecular Biology, Genetics and Ophthalmology. According to data from OpenAlex, Daniel M. Lipinski has authored 38 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 19 papers in Genetics and 15 papers in Ophthalmology. Recurrent topics in Daniel M. Lipinski's work include Retinal Development and Disorders (27 papers), Virus-based gene therapy research (18 papers) and Retinal Diseases and Treatments (12 papers). Daniel M. Lipinski is often cited by papers focused on Retinal Development and Disorders (27 papers), Virus-based gene therapy research (18 papers) and Retinal Diseases and Treatments (12 papers). Daniel M. Lipinski collaborates with scholars based in United States, United Kingdom and Canada. Daniel M. Lipinski's co-authors include Robert E. MacLaren, Alun R. Barnard, Mandeep S. Singh, Peter Charbel Issa, Miriam Thake, Chris Martin, Rachel Butler, Sumathi Sekaran, Samantha R. De Silva and Thomas B. Connor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Daniel M. Lipinski

37 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel M. Lipinski United States 16 800 295 253 218 138 38 916
Hilda Petrs‐Silva Brazil 14 840 1.1× 214 0.7× 188 0.7× 390 1.8× 88 0.6× 35 964
Claire Hippert United Kingdom 13 994 1.2× 254 0.9× 483 1.9× 158 0.7× 166 1.2× 17 1.2k
Elena Marrocco Italy 18 839 1.0× 184 0.6× 153 0.6× 261 1.2× 56 0.4× 27 969
Selina A. Azam United Kingdom 8 634 0.8× 161 0.5× 282 1.1× 159 0.7× 78 0.6× 9 709
R. R. Klimczak United States 8 1.2k 1.4× 307 1.0× 268 1.1× 578 2.7× 141 1.0× 10 1.3k
Louisa M. Affatigato United States 13 1.0k 1.3× 620 2.1× 247 1.0× 160 0.7× 194 1.4× 17 1.2k
Xufeng Dai China 12 558 0.7× 251 0.9× 193 0.8× 126 0.6× 81 0.6× 20 609
Thérèse Cronin France 13 678 0.8× 166 0.6× 286 1.1× 176 0.8× 53 0.4× 18 734
Ivana Trapani Italy 15 882 1.1× 226 0.8× 165 0.7× 369 1.7× 75 0.5× 18 963
Christine N. Kay United States 13 871 1.1× 504 1.7× 131 0.5× 372 1.7× 212 1.5× 45 1.2k

Countries citing papers authored by Daniel M. Lipinski

Since Specialization
Citations

This map shows the geographic impact of Daniel M. Lipinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Lipinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Lipinski more than expected).

Fields of papers citing papers by Daniel M. Lipinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel M. Lipinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Lipinski. The network helps show where Daniel M. Lipinski may publish in the future.

Co-authorship network of co-authors of Daniel M. Lipinski

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel M. Lipinski. A scholar is included among the top collaborators of Daniel M. Lipinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel M. Lipinski. Daniel M. Lipinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderson, David M., et al.. (2025). Porcine Sub-Retinal Pigment Epithelium Deposits: A Model for Dry Age-Related Macular Degeneration With Comparison to Human Drusen. Investigative Ophthalmology & Visual Science. 66(3). 18–18.
2.
Kandoi, Sangeetha, Hannah M. Follett, Phyllis Summerfelt, et al.. (2024). Human iPSC-derived photoreceptor transplantation in the cone dominant 13-lined ground squirrel. Stem Cell Reports. 19(3). 331–342. 9 indexed citations
3.
Lipinski, Daniel M., et al.. (2024). Characterization of drusen formation in a primary porcine tissue culture model of dry AMD. Molecular Therapy — Methods & Clinical Development. 32(4). 101331–101331. 4 indexed citations
4.
Lawrence, Matthew S., et al.. (2023). Tolerability and tropism of recombinant adeno-associated virus vectors in the African green monkey (Chlorocebus sabaeus) anterior chamber. Gene Therapy. 30(9). 714–722. 1 indexed citations
5.
Boye, Sanford L., et al.. (2023). Improving retinal vascular endothelial cell tropism through rational rAAV capsid design. PLoS ONE. 18(5). e0285370–e0285370. 1 indexed citations
6.
Liu, Haoyuan, et al.. (2022). rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis. Gene Therapy. 30(3-4). 297–308. 3 indexed citations
7.
Reid, Christopher A., et al.. (2022). Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats. Communications Biology. 5(1). 1169–1169. 14 indexed citations
8.
Lipinski, Daniel M., et al.. (2021). Optimizing transfection and transduction-based gene delivery in primary and immortalized RPE cells. Investigative Ophthalmology & Visual Science. 62(8). 2696–2696. 1 indexed citations
9.
Merriman, Dana K., et al.. (2020). Electroretinogram of the Cone-Dominant Thirteen-Lined Ground Squirrel during Euthermia and Hibernation in Comparison with the Rod-Dominant Brown Norway Rat. Investigative Ophthalmology & Visual Science. 61(6). 6–6. 9 indexed citations
10.
Lipinski, Daniel M.. (2019). A Comparison of Inducible Gene Expression Platforms: Implications for Recombinant Adeno-Associated Virus (rAAV) Vector-Mediated Ocular Gene Therapy. Advances in experimental medicine and biology. 1185. 79–83. 5 indexed citations
11.
Merriman, Dana K., et al.. (2019). Intravitreal Delivery of rAAV2 Vectors to the 13-Lined Ground Squirrel Retina. Investigative Ophthalmology & Visual Science. 60(9). 2896–2896. 1 indexed citations
12.
Hasan, Nazarul, et al.. (2019). Presynaptic Expression of LRIT3 Transsynaptically Organizes the Postsynaptic Glutamate Signaling Complex Containing TRPM1. Cell Reports. 27(11). 3107–3116.e3. 35 indexed citations
13.
Sikora, Jakub, et al.. (2018). Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment. American Journal Of Pathology. 189(2). 320–338. 19 indexed citations
14.
Lipinski, Daniel M., et al.. (2017). Intravitreal transduction profile of recombinant adeno-associated virus in murine and human retina. Investigative Ophthalmology & Visual Science. 58(8). 291–291. 3 indexed citations
15.
Silva, Samantha R. De, Peter Charbel Issa, Mandeep S. Singh, et al.. (2016). Single residue AAV capsid mutation improves transduction of photoreceptors in the Abca4−/− mouse and bipolar cells in the rd1 mouse and human retina ex vivo. Gene Therapy. 23(11). 767–774. 26 indexed citations
16.
Lipinski, Daniel M., Sanford L. Boye, Jim Peterson, et al.. (2015). Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus After Intravenous Injection. Human Gene Therapy. 26(11). 767–776. 13 indexed citations
17.
Lipinski, Daniel M., Alun R. Barnard, Mandeep S. Singh, et al.. (2015). CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa. Molecular Therapy. 23(8). 1308–1319. 63 indexed citations
19.
Lipinski, Daniel M., Miriam Thake, & Robert E. MacLaren. (2012). Clinical applications of retinal gene therapy. Progress in Retinal and Eye Research. 32. 22–47. 101 indexed citations
20.
Yusuf, Mohammed, David L.V. Bauer, Daniel M. Lipinski, et al.. (2011). Combining M-FISH and Quantum Dot technology for fast chromosomal assignment of transgenic insertions. BMC Biotechnology. 11(1). 121–121. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026